The Government of Canada has announced its intention to merge BDC and EDC. Today, BDC remains BDC, and we remain fully committed to Canadian entrepreneurs. Learn more

The Government of Canada has announced its intention to merge BDC and EDC. Today, BDC remains BDC, and we remain fully committed to Canadian entrepreneurs. Learn more
FR
Search
Search
Interface Biologics Inc. logo
Portfolio company

Interface Biologics Inc.

Details
Region
Ontario
Industry sector
Devices
Investment year
2005
Fund
Healthcare Venture Fund
Learn more
Our partnership

Interface is a BDC Capital Healthcare Venture Fund company, co-managed in partnership by Amplitude Venture Capital.

Contact

Dion Madsen, Founding partner at Amplitude Venture Capital.

About the company

Interface Biologics is a privately held early commercial stage company that develops transformative biomedical polymer technology to improve the safety and effectiveness of medical devices.